Kraus & Weisert’s biotech team consists of experienced patent attorneys and younger attorneys/trainees who have recently left university research. The team is able to cover a wide variety of biological, biomedical and biotechnological inventions including recombinant proteins, molecule diagnostics (SNP arrays, microsatellite DNA typing, PCR-based methods), gene therapy, various types of antibodies, RNA, biomarkers, vaccines, stem cells, transgenic plants and animals, bioinformatics methods, plant breeding innovations and microfluidic devices.

Kraus & Weisert is representing numerous biotechnology companies. The freedom to operate in the life science sector of larger companies is today fairly often restricted or totally blocked by basic patents. Kraus & Weisert has ample experience in opposition, appeal and nullity proceedings with respect to such issues.

Biotechnological inventions often require interdisciplinary skill and counseling. Since Kraus & Weisert has scientifically trained patent attorneys and patent experts specializing in all major areas of modern technology a competent and full service can be offered for such cases.

Finally, Kraus & Weisert is part of an expert network in the biotech field. This allows us to bring our clients in contact with useful expertise concerning, inter alia, business development, start-up financing and regulatory approval.